# Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab

> **NCT06741553** · — · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 120 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment (MCI)

## Interventions

- **DRUG:** Lecanemab 10 mg/kg

## Key facts

- **NCT ID:** NCT06741553
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-28
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741553, "Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06741553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*